148 related articles for article (PubMed ID: 16480270)
1. Novel human lipoxygenase inhibitors discovered using virtual screening with homology models.
Kenyon V; Chorny I; Carvajal WJ; Holman TR; Jacobson MP
J Med Chem; 2006 Feb; 49(4):1356-63. PubMed ID: 16480270
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.
Vasquez-Martinez Y; Ohri RV; Kenyon V; Holman TR; Sepúlveda-Boza S
Bioorg Med Chem; 2007 Dec; 15(23):7408-25. PubMed ID: 17869117
[TBL] [Abstract][Full Text] [Related]
3. Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries.
Deschamps JD; Gautschi JT; Whitman S; Johnson TA; Gassner NC; Crews P; Holman TR
Bioorg Med Chem; 2007 Nov; 15(22):6900-8. PubMed ID: 17826100
[TBL] [Abstract][Full Text] [Related]
4. In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases.
Mascayano C; Espinosa V; Sepúlveda-Boza S; Hoobler EK; Perry S
Chem Biol Drug Des; 2013 Sep; 82(3):317-25. PubMed ID: 23663316
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.
Rai G; Kenyon V; Jadhav A; Schultz L; Armstrong M; Jameson JB; Hoobler E; Leister W; Simeonov A; Holman TR; Maloney DJ
J Med Chem; 2010 Oct; 53(20):7392-404. PubMed ID: 20866075
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors.
Iranshahi M; Jabbari A; Orafaie A; Mehri R; Zeraatkar S; Ahmadi T; Alimardani M; Sadeghian H
Eur J Med Chem; 2012 Nov; 57():134-42. PubMed ID: 23047230
[TBL] [Abstract][Full Text] [Related]
7. Kinetic investigations of the rate-limiting step in human 12- and 15-lipoxygenase.
Segraves EN; Holman TR
Biochemistry; 2003 May; 42(18):5236-43. PubMed ID: 12731864
[TBL] [Abstract][Full Text] [Related]
8. Kinetic and structural investigations of the allosteric site in human epithelial 15-lipoxygenase-2.
Wecksler AT; Kenyon V; Garcia NK; Deschamps JD; van der Donk WA; Holman TR
Biochemistry; 2009 Sep; 48(36):8721-30. PubMed ID: 19645454
[TBL] [Abstract][Full Text] [Related]
9. Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases.
Deschamps JD; Kenyon VA; Holman TR
Bioorg Med Chem; 2006 Jun; 14(12):4295-301. PubMed ID: 16500106
[TBL] [Abstract][Full Text] [Related]
10. Lipoxygenase inhibition by anadanthoflavone, a new flavonoid from the aerial parts of Anadenanthera colubrina.
Gutierrez-Lugo MT; Deschamps JD; Holman TR; Suarez E; Timmermann BN
Planta Med; 2004 Mar; 70(3):263-5. PubMed ID: 15114507
[TBL] [Abstract][Full Text] [Related]
11. Inhibition studies of soybean and human 15-lipoxygenases with long-chain alkenyl sulfate substrates.
Mogul R; Holman TR
Biochemistry; 2001 Apr; 40(14):4391-7. PubMed ID: 11284695
[TBL] [Abstract][Full Text] [Related]
12. Redox inactivation of human 15-lipoxygenase by marine-derived meroditerpenes and synthetic chromanes: archetypes for a unique class of selective and recyclable inhibitors.
Cichewicz RH; Kenyon VA; Whitman S; Morales NM; Arguello JF; Holman TR; Crews P
J Am Chem Soc; 2004 Nov; 126(45):14910-20. PubMed ID: 15535718
[TBL] [Abstract][Full Text] [Related]
13. A combinatorial approach for the discovery of drug-like inhibitors of 15-lipoxygenase-1.
van der Vlag R; Guo H; Hapko U; Eleftheriadis N; Monjas L; Dekker FJ; Hirsch AKH
Eur J Med Chem; 2019 Jul; 174():45-55. PubMed ID: 31026746
[TBL] [Abstract][Full Text] [Related]
14. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
[TBL] [Abstract][Full Text] [Related]
15. Effect of catechol derivatives on cell growth and lipoxygenase activity.
Simpson J; Forrester R; Tisdale MJ; Billington DC; Rathbone DL
Bioorg Med Chem Lett; 2003 Aug; 13(15):2435-9. PubMed ID: 12852938
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biochemical evaluation of benzyl propargyl ethers as inhibitors of 5-lipoxygenase.
Barhate NB; Reddy MC; Reddy PS; Wakharkar RD; Reddanna P
Indian J Biochem Biophys; 2002 Aug; 39(4):264-73. PubMed ID: 22908417
[TBL] [Abstract][Full Text] [Related]
17. Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase.
Ngu K; Weinstein DS; Liu W; Langevine C; Combs DW; Zhuang S; Chen X; Madsen CS; Harper TW; Ahmad S; Robl JA
Bioorg Med Chem Lett; 2011 Jul; 21(14):4141-5. PubMed ID: 21696952
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
19. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
[TBL] [Abstract][Full Text] [Related]
20. A potent and selective inhibitor targeting human and murine 12/15-LOX.
Armstrong MM; Freedman CJ; Jung JE; Zheng Y; Kalyanaraman C; Jacobson MP; Simeonov A; Maloney DJ; van Leyen K; Jadhav A; Holman TR
Bioorg Med Chem; 2016 Mar; 24(6):1183-90. PubMed ID: 26899595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
